US Stock MarketDetailed Quotes
MRKR Marker Therapeutics
- 3.6400
- -0.0800-2.15%
Close Nov 13 16:00 ET
- 3.6500
- +0.0100+0.27%
Post 16:54 ET
32.48MMarket Cap-3111P/E (TTM)
3.9000High3.6000Low23.68KVolume3.8100Open3.7200Pre Close87.43KTurnover0.35%Turnover RatioLossP/E (Static)8.92MShares6.156852wk High3.35P/B24.62MFloat Cap2.437752wk Low--Dividend TTM6.76MShs Float2447.9980Historical High--Div YieldTTM8.07%Amplitude0.6700Historical Low3.6920Avg Price1Lot Size
Marker Therapeutics News
Ladenburg Thalmann Maintains Marker Therapeutics(MRKR.US) With Buy Rating, Raises Target Price to $19
Marker Therapeutics Price Target Raised to $19.00/Share From $11.00 by Ladenburg Thalmann
Marker Therapeutics Is Maintained at Buy by Ladenburg Thalmann
Marker Therapeutics Analyst Ratings
Marker Therapeutics Analyst Ratings
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data